GSK worked with Kenco Logistic Services for a coordinated launch
Commercial teams can prepare for overcoming predictable hurdles
The second edition of an essential business planner's library
Addressing continued hurdles in patient adherence
DEA’s manufacturer and distributor data-collection requirements are changing
Evaluating medicine and healthcare by their outcomes is now an NIH priority
Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis
The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity
Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?
A 'performance curve' chart for containers could simplify the design process
A double-digit growth rate through 2024 means boom times for drug-delivery devices and for contract manufacturing services
Ultralow temperatures require a revision of vaccine distribution technology
Drug companies should keep a goal of effective communications as the priority in medical publications
The case for a single enterprise-wide learning management system
"If we had asked them, they would have asked for faster horses." ~ Henry Ford
More personal control over healthcare and the desire for more access to information drive consumer attitudes
GSK invests in online resources to address ‘the whole patient’
Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial
True 'market access' should involve coordinated approaches to patients and their healthcare providers
The growing complexity of managed-markets contract support makes outsourcing a near-necessity for Small Pharma, and a better option for Big Pharma
Recent product contamination incidents are highlighting the importance of having reliably clean pallets for warehousing and shipping
Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.
Technology is enabling more resources to reach the medical affairs teams—in a compliant manner
Good design of vaults and cages for DEA-regulated materials calls for meeting regulatory requirements while accommodating operational practices
How drugmakers can navigate the program’s pricing challenges and regulatory developments.
Taking a market-by-market approach to maximizing value after loss of exclusivity